Related Experiment Videos
Some immunological parameters in Hodgkin's disease.
Z Dienstbier1, Z Hermanská, P Pĕnicka
1Institute of Biophysics and Nuclear Medicine, Faculty of General Medicine, Charles University, Prague, Czechoslovakia.
Neoplasma
|January 1, 1988
Summary
Peripheral blood mononuclear cells in Hodgkin
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Hodgkin's disease is a cancer of the lymphatic system.
- Immune system alterations are common in Hodgkin's disease patients.
- Understanding these immune changes is crucial for prognosis and treatment.
Purpose of the Study:
- To investigate changes in peripheral blood mononuclear cells in Hodgkin's disease patients.
- To correlate these changes with disease stage and symptoms.
- To assess the impact of treatment on immune cell profiles.
Main Methods:
- Analysis of mononuclear cells from 69 untreated Hodgkin's disease patients.
- Follow-up studies during and after treatment.
- Discriminant analysis to evaluate immunocompetence.
Main Results:
- Decreased lymphocytes, E-rosette forming cells, and increased ferritin-bearing lymphocytes pre-treatment.
- Advanced disease showed more pronounced changes in resting cells.
- Immune cell imbalances persisted 1-2 years post-treatment, impacting immunocompetence.
Conclusions:
- Peripheral blood mononuclear cell alterations are significant in Hodgkin's disease.
- These changes correlate with disease severity and B symptoms.
- Persistent T-lymphocyte subpopulation imbalance contributes to long-term immune defects post-therapy.